Skye Bioscience, Inc. Files SEC Form 8-K, Current Report: (Oct. 29, 2024).

Skye Bioscience, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 29, 2024. This form is used to report material events or corporate changes that are important to investors. The company's SIC code is 2834, Pharmaceutical Preparations, and the filing can be accessed on the SEC's website. For more information, visit https://www.sec.gov/Archives/edgar/data/1516551/0001516551-24-000093-index.html. [Extracted from the article]